Levetiracetam Ucb

Levetiracetam, the active ingredient in Levetiracetam Ucb, is an antiepileptic presented as an oral tablet for oral use. It is employed to control partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy across various age groups.

GNH USA supplies Levetiracetam Ucb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medication for seizure management. The company adheres to stringent quality standards, ensuring product integrity throughout the supply chain, and supports regulatory compliance for global distribution.

Levetiracetam is an antiepileptic drug used to treat several seizure types by stabilizing neuronal activity.

Partial seizures: decreases the number of focal onset seizures and helps achieve better seizure control in patients with localized epilepsy. Generalized tonic‑clonic seizures: suppresses bilateral convulsive activity, reducing the occurrence of full‑body shaking episodes in generalized epilepsy. Myoclonic seizures: lessens sudden, brief muscle jerks, improving daily functioning for individuals with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Headache - Irritability - Nausea - Nasal congestion

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis) - Mood changes including depression or suicidal thoughts - Blood disorders such as neutropenia or thrombocytopenia - Stevens‑Johnson syndrome - Hepatic injury

When prescribing Levetiracetam, clinicians should consider several safety factors.

Renal impairment: dose may need adjustment in patients with reduced kidney function. Hepatic dysfunction: monitor liver enzymes, especially in patients with existing liver disease. Psychiatric symptoms: observe for mood changes, depression, or aggression. Concomitant CNS depressants: use caution as combined effects may increase sedation. Pregnancy and lactation: safety not established; weigh benefits against potential risks. Store below 25°C: keep in the original pack, protect from moisture.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels, decreasing seizure control. - Phenobarbital: can reduce levetiracetam concentrations, necessitating close monitoring.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression and dizziness. - Other antiepileptic drugs (e.g., valproate): may require dose adjustments. - Oral contraceptives: levetiracetam may slightly reduce hormonal efficacy; consider alternative contraception.